Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > LIFE aTyr Pharma > Detailed Quotes

LIFE aTyr Pharma

2.780
-0.100-3.47%
Close 10/06 16:00 ET
2.7800.0000.00%
Post Mkt Price 10/06 16:00 ET
High
2.910
Open
2.850
Turnover
181.45K
Low
2.770
Pre Close
2.880
Volume
64.66K
Market Cap
79.58M
P/E(TTM)
Loss
52wk High
9.950
Shares
28.63M
P/E(Static)
Loss
52wk Low
2.600
Float Cap
77.14M
Bid/Ask %
96.08%
Historical High
396.060
Shs Float
27.75M
Volume Ratio
0.91
Historical Low
2.130
Dividend TTM
--
Div Yield TTM
--
P/B
0.92
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.23%
Amplitude
4.86%
Avg Price
2.806
Lot Size
1
Float Cap
77.14M
Bid/Ask %
96.08%
Historical High
396.060
Shs Float
27.75M
Volume Ratio
0.91
Historical Low
2.130
Dividend TTM
--
P/B
0.92
Dividend LFY
--
Turnover Ratio
0.23%
Amplitude
4.86%
Avg Price
2.806
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
CEO: Dr. Sanjay S. Shukla, M.D.,M.S.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...